Shima Uneda

657 total citations
17 papers, 495 citations indexed

About

Shima Uneda is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Shima Uneda has authored 17 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Shima Uneda's work include Angiogenesis and VEGF in Cancer (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer Cells and Metastasis (4 papers). Shima Uneda is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer Cells and Metastasis (4 papers). Shima Uneda collaborates with scholars based in Japan and United States. Shima Uneda's co-authors include Ben K. Seon, Hilda Tsai, Naoko Harada, Masanori Tsujie, Fumihiko Matsuno, Tomoko Tsujie, Hirofumi Toi, Hiroyuki Hata, Hiroaki Mitsuya and Takashi Sonoki and has published in prestigious journals such as International Journal of Cancer, British Journal of Haematology and Molecular Cancer Therapeutics.

In The Last Decade

Shima Uneda

17 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shima Uneda Japan 11 264 189 124 100 64 17 495
Daniel Trageser United States 6 277 1.0× 190 1.0× 141 1.1× 124 1.2× 31 0.5× 8 629
MS Wicha United States 6 289 1.1× 346 1.8× 136 1.1× 115 1.1× 75 1.2× 9 639
Iker Antón Spain 9 305 1.2× 225 1.2× 214 1.7× 39 0.4× 38 0.6× 15 538
Yuri Miyazawa Japan 10 223 0.8× 160 0.8× 69 0.6× 55 0.6× 43 0.7× 33 464
Maria C. Melander Denmark 13 175 0.7× 215 1.1× 201 1.6× 40 0.4× 43 0.7× 18 584
Takahiro Heishi Japan 10 298 1.1× 206 1.1× 118 1.0× 42 0.4× 39 0.6× 16 586
Deeksha Vishwamitra United States 11 214 0.8× 191 1.0× 121 1.0× 63 0.6× 53 0.8× 27 492
Ana‐Violeta Fonseca Germany 7 213 0.8× 191 1.0× 75 0.6× 60 0.6× 74 1.2× 7 413
Rebecca A. Wagenaar-Miller United States 8 253 1.0× 212 1.1× 257 2.1× 52 0.5× 49 0.8× 8 584
Barbara K. Zehentner United States 17 394 1.5× 298 1.6× 249 2.0× 124 1.2× 26 0.4× 35 818

Countries citing papers authored by Shima Uneda

Since Specialization
Citations

This map shows the geographic impact of Shima Uneda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shima Uneda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shima Uneda more than expected).

Fields of papers citing papers by Shima Uneda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shima Uneda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shima Uneda. The network helps show where Shima Uneda may publish in the future.

Co-authorship network of co-authors of Shima Uneda

This figure shows the co-authorship network connecting the top 25 collaborators of Shima Uneda. A scholar is included among the top collaborators of Shima Uneda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shima Uneda. Shima Uneda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Uneda, Shima, et al.. (2017). Retroperitoneal Bulky Histiocytic Sarcoma Successfully Treated with Induction Chemotherapy Followed by Curative Surgery. Internal Medicine. 56(20). 2765–2768. 1 indexed citations
2.
Uneda, Shima, et al.. (2015). Prognostic Factors and Outcomes of Adult-Onset Hemophagocytic Lymphohistiocytosis: A Retrospective Analysis of 34 Cases. Hematology Reports. 7(2). 5841–5841. 13 indexed citations
3.
Uneda, Shima, et al.. (2014). Successful Use of Extracorporeal Membrane Oxygenation for Respiratory Failure Caused by Mediastinal Precursor T Lymphoblastic Lymphoma. Case Reports in Medicine. 2014. 1–4. 10 indexed citations
4.
Seon, Ben K., Akinao Haba, Fumihiko Matsuno, et al.. (2010). Endoglin-Targeted Cancer Therapy. Current Drug Delivery. 8(1). 135–143. 110 indexed citations
5.
Uneda, Shima, Shogo Murata, Takashi Sonoki, Hiroshi Matsuoka, & Hideki Nakakuma. (2009). Successful treatment with liposomal doxorubicin for widespread Kaposi’s sarcoma and human herpesvirus-8 related severe hemophagocytic syndrome in a patient with acquired immunodeficiency syndrome. International Journal of Hematology. 89(2). 195–200. 7 indexed citations
6.
Uneda, Shima, Hirofumi Toi, Tomoko Tsujie, et al.. (2009). Anti‐endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculature. International Journal of Cancer. 125(6). 1446–1453. 54 indexed citations
7.
Seon, Ben K., Yuro Haruta, Fumihiko Matsuno, et al.. (2009). Receptor-targeted anticancer therapy. Immunologic Research. 46(1-3). 189–191. 1 indexed citations
8.
Uneda, Shima, Takashi Sonoki, Kazuhiro Nishida, et al.. (2008). Establishment of CD5 and CD10 double-positive mature B-cell line, WILL1, showing complex 8q24 translocation involving 14q32 and 6q27. International Journal of Hematology. 88(5). 536–542. 1 indexed citations
9.
Sonoki, Takashi, et al.. (2008). Aggressive CD5-positive B-cell lymphoma after remission of CD5-negative follicular lymphoma with distinct immunoglobulin heavy chain rearrangement and translocation. International Journal of Hematology. 88(3). 299–303. 3 indexed citations
10.
Tsujie, Masanori, Tomoko Tsujie, Hirofumi Toi, et al.. (2008). Anti‐tumor activity of an anti‐endoglin monoclonal antibody is enhanced in immunocompetent mice. International Journal of Cancer. 122(10). 2266–2273. 46 indexed citations
11.
Uneda, Shima, et al.. (2008). Rapid Vanishing of Tumors by Withdrawal of Methotrexate in Epstein-Barr Virus-Related B cell Lymphoproliferative Disorder. Internal Medicine. 47(15). 1445–1446. 17 indexed citations
12.
Nakamura, Miki, Tomomi Gotoh, Yutaka Okuno, et al.. (2006). Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells. Leukemia & lymphoma. 47(3). 531–539. 55 indexed citations
13.
Tsujie, Masanori, Shima Uneda, Hilda Tsai, & Ben K. Seon. (2006). Effective anti-angiogenic therapy of established tumors in mice by naked anti-human endoglin (CD105) antibody: Differences in growth rate and therapeutic response between tumors growing at different sites. International Journal of Oncology. 29(5). 1087–94. 34 indexed citations
14.
Harada, Naoko, William R. Greco, Akinao Haba, et al.. (2005). Antiangiogenic chimeric anti-endoglin (CD105) antibody: pharmacokinetics and immunogenicity in nonhuman primates and effects of doxorubicin. Cancer Immunology Immunotherapy. 55(2). 140–150. 28 indexed citations
15.
Tatetsu, Hiro, Yutaka Okuno, Miki Nakamura, et al.. (2005). Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, induces apoptosis in multiple myeloma cells in an IκBα-independent manner. Molecular Cancer Therapeutics. 4(7). 1114–1120. 32 indexed citations
16.
17.
Uneda, Shima, Hiroyuki Hata, Fumihiko Matsuno, et al.. (2002). Macrophage inflammatory protein‐1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM. British Journal of Haematology. 120(1). 53–55. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Trageser Breakdown of academic impact, for papers by MS Wicha Breakdown of academic impact, for papers by Iker Antón Breakdown of academic impact, for papers by Yuri Miyazawa Breakdown of academic impact, for papers by Maria C. Melander Breakdown of academic impact, for papers by Takahiro Heishi Breakdown of academic impact, for papers by Deeksha Vishwamitra Breakdown of academic impact, for papers by Ana‐Violeta Fonseca Breakdown of academic impact, for papers by Rebecca A. Wagenaar-Miller Breakdown of academic impact, for papers by Barbara K. Zehentner
Rankless by CCL
2026